ReleaseWire Connect

According to Fact.MR's research report on the global cell lines market, the market is anticipated to show a moderate growth rate during the forecasted period of 2017-2022 and expected to reflect a value of more than US$ 140 Mn.

Proteins resulting from expression of recombinant DNA (rDNA), within living cells, are known as recombinant proteins. rDNAs are DNA molecules that are formed by laboratory procedures of genetic recombination, to bring genetic material together from multiple sources. DNA sequences used for constructing recombinant DNA molecules originate from any species. If the DNA sequences do not occur in nature, they can be created through chemical synthesis of DNA, further incorporating them into recombinant molecules.

According to Fact.MR's research report on the global peptide based metabolic disorders therapeutics market, the market is anticipated to show a robust growth rate during the forecasted period of 2017-2022 and expected to reflect a value more than US$ 8 Bn.

There is a need to develop novel therapeutic agents in order to fight infections. Peptide therapeutics are used to fight infectious diseases. The global peptide based infection therapeutics market is expected to grow in the future owing to factors such as cost effectiveness of peptides, higher efficacy of peptides in managing various disease indications and infections, and can be easily synthesized owing to smaller size. Moreover, few economic factors such as government policies for startup companies, increasing foreign direct investment, as well as higher investment in healthcare are also driving the global peptide based infection therapeutics market. The rising prevalence of infectious diseases has resulted in providing an impetus to the use of peptides therapeutics to treat infections. Along with this, emerging biotech and pharmaceutical companies, strong and advanced pipelines and patent expiries are few other aspects impacting the growth of the global peptide based infection therapeutics market positively. To support this, the advancements in technology and increased research and development and the rising investments in these fields have led to the growing importance of global peptide based infection therapeutics market. North America is expected to show higher attractiveness in this market.

This Fact.MR report on the global peptide based hematological disorders therapeutics market forecasts that the global peptide based hematological disorders therapeutics market will touch a value of nearly US$ 530 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

Pharmaceutical companies are increasingly collaborating with medical institutes and research centers in order to ramp up R&D pipelines of peptide drugs. This is expected to influence the growth of the global peptide based gastrointestinal disorders therapeutics market over the next couple of years. Rising prevalence of metabolic diseases and gastrointestinal disorders pertaining to the digestive system is prompting medical practitioners to utilize new therapeutics including peptides. In the near future, application of peptides is also expected to increase in other therapeutic areas as well. Moreover, technological advancement in peptide synthesis which include hybrid combination of liquid and solid synthesis and high-throughput approaches is expected to play a crucial role in development of more effective peptide based therapeutic drugs for treating gastrointestinal disorders. Such developments in the peptide therapeutics is also giving new hope to patients seeking affordable and effect therapeutic treatments. In addition, manufacturers are actively focusing on improving peptide properties, such as half-life and stability to address the various unmet medical needs. According to the latest report published by Fact.MR, the global peptide based gastrointestinal disorders therapeutics market is set to reflect a double-digit CAGR between 2017 and 2022, to surpass a valuation of US$ 600 Mn.

This Fact.MR report on the global peptide based cardiovascular therapeutics market forecasts that the global peptide based cardiovascular therapeutics market will touch a value of nearly US$ 1,960 Mn in the year 2022 and grow at a robust CAGR during the assessment period.

This Fact.MR report on the global platelet-rich plasma market forecasts that the global platelet-rich plasma market will touch a value of nearly US$ 391 Mn in the year 2022 and grow at a robust CAGR during the assessment period, 2017-2022.

Fact.MR has announced the addition of the “Cooler Connected to the Mains Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2026"report to their offering.

Fact.MR has announced the addition of the “Alcohol Ethoxylate Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2027"report to their offering.